These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6326647)

  • 1. Interactions between C3b and cell-surface macromolecules.
    Levine RP; Finn R; Gross R
    Ann N Y Acad Sci; 1983; 421():235-45. PubMed ID: 6326647
    [No Abstract]   [Full Text] [Related]  

  • 2. Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.
    Takahashi M; Takahashi S; Hirose S
    Prog Allergy; 1980; 27():134-66. PubMed ID: 6986046
    [No Abstract]   [Full Text] [Related]  

  • 3. Multifactorial basis of C3b receptor reactivity.
    Dierich MP; Schulz TF
    Mol Immunol; 1984 Dec; 21(12):1201-4. PubMed ID: 6395003
    [No Abstract]   [Full Text] [Related]  

  • 4. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third component of human complement: C3.
    Berger M
    Methods Enzymol; 1990; 184():619-28. PubMed ID: 2143801
    [No Abstract]   [Full Text] [Related]  

  • 6. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
    Kalli KR; Hsu PH; Bartow TJ; Ahearn JM; Matsumoto AK; Klickstein LB; Fearon DT
    J Exp Med; 1991 Dec; 174(6):1451-60. PubMed ID: 1836011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complement, a system of recognition of activation and amplification].
    Peltier AP; Kazatchkine MD
    Ann Immunol (Paris); 1982; 133C(2):149-54. PubMed ID: 6921958
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes.
    Leist-Welsh P; Bjornson AB
    J Immunol; 1982 Jun; 128(6):2643-51. PubMed ID: 6210733
    [No Abstract]   [Full Text] [Related]  

  • 11. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of macrophage complement receptor function in vitro. III. C3b receptors that promote phagocytosis migrate within the plane of the macrophage plasma membrane.
    Griffin FM; Mullinax PJ
    J Exp Med; 1981 Aug; 154(2):291-305. PubMed ID: 7264560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative pathway of complement by apoptotic Jurkat cells.
    Matsui H; Tsuji S; Nishimura H; Nagasawa S
    FEBS Lett; 1994 Sep; 351(3):419-22. PubMed ID: 7521852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human glomerular C3 receptor.
    Fischer E; Appay MD; Kazatchkine MD
    Mol Immunol; 1984 Dec; 21(12):1223-7. PubMed ID: 6395004
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and characterization of a C3b receptor-like molecule from membranes of a human B lymphoblastoid cell line (Raji).
    Barel M; Charriaut C; Frade R
    FEBS Lett; 1981 Dec; 136(1):111-4. PubMed ID: 6976275
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.